POLYNEUROPATHIES
Clinical trials for POLYNEUROPATHIES explained in plain language.
Never miss a new study
Get alerted when new POLYNEUROPATHIES trials appear
Sign up with your email to follow new studies for POLYNEUROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare nerve disease? early trial tests patisiran
Disease control OngoingThis early-phase study tests the drug patisiran in 10 adults with a rare disease called wild-type ATTR amyloidosis that causes nerve damage. The goal is to see if patisiran can improve nerve function and quality of life over 24 months. Participants will have regular check-ups and…
Matched conditions: POLYNEUROPATHIES
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Desperate man gets experimental stem cells for rare nerve disease
Symptom relief NO_LONGER_AVAILABLEThis study tested a stem cell treatment for a 58-year-old man with nerve damage caused by POEMS syndrome. He received eight infusions of his own stem cells over 28 weeks to help relieve symptoms. The study is no longer available and only included one person.
Matched conditions: POLYNEUROPATHIES
Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated May 17, 2026 02:34 UTC